With a market capitalization of Rs 1,362 crores, the shares of Capacite Infraprojects Limited are trading at Rs 201, zooming 6.10 percent as compared to the previous close of Rs 189.10. In the last one month, the stock has jumped over 17 percent ranging from Rs 171.15 at the end of May to the current levels prevailing in the markets.
The company, through a regulatory filing with the Bombay Stock Exchange (BSE) today, informed that it received an order worth Rs 452.50 crores. The order is awarded by a reputed client (private sector) for the purpose of construction of commercial as well as residential towers in the National Capital Region (NCR).
The consolidated financials of Capacite Infraprojects, on an annual basis, portray operating revenues of Rs 1,798 crores as compared to the revenues of Rs 1,334 crores in the previous financial year. Moreover, the net profit numbers went up from Rs 44 crores to Rs 94 crores.
The profitability ratios, maintaining a healthy pace, have improved in the past couple of years with the return on equity (ROE) moving from 4.52 percent during FY21-22 to 8.87 percent in FY22-23 and the return on capital employed (ROCE), during the same period, taking a shift from 9.27 percent to 15.86 percent.
According to the shareholding pattern data available for the March 2023 quarter, the Promoters hold a 38.65 percent stake (19.06 percent as pledged), and Foreign Institutional Investors (FIIs) hold a 6.52 percent stake in the company.
Headquartered in Mumbai, Capacit’e Infraprojects Limited is involved in the business of the construction of buildings with a specialization in high-rise, institutional buildings. Some of its projects include Oberoi Garden City, Rustomjee Seasons, Tata Trust, etc.
Written by Amit Madnani
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
